Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.09
-22.3%
$0.10
$0.06
$0.47
$6.61M0.76570,807 shs2.31 million shs
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$88.57
-0.6%
$82.29
$57.18
$90.63
$63.34B1.054.06 million shs811,032 shs
FAP
abrdn Asia-Pacific Income Fund VCC
C$2.92
-1.0%
C$2.89
C$2.55
C$3.04
C$107.64M0.5453,748 shs12,601 shs
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
$214.90
0.0%
$199.29
$166.48
$240.28
$21.19B1.233.43 million shs1.34 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.00%0.00%0.00%-32.30%-73.81%
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
+0.17%-0.07%+11.11%+0.19%+54.13%
FAP
abrdn Asia-Pacific Income Fund VCC
+1.03%0.00%+3.87%+1.37%+13.03%
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
+0.04%+1.13%+7.99%-0.46%+23.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
1.6436 of 5 stars
3.50.00.00.00.61.70.6
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
4.6932 of 5 stars
2.33.04.22.12.82.53.1
FAP
abrdn Asia-Pacific Income Fund VCC
N/AN/AN/AN/AN/AN/AN/AN/A
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
3.00
Buy$2.752,908.75% Upside
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
2.57
Moderate Buy$92.083.96% Upside
FAP
abrdn Asia-Pacific Income Fund VCC
0.00
N/AN/AN/A
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
2.65
Moderate Buy$215.270.17% Upside

Current Analyst Ratings Breakdown

Latest FAP, BK, XLY, and AIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$87.00 ➝ $97.00
4/14/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$90.00 ➝ $87.00
4/4/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$93.00 ➝ $90.00
4/2/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$99.00 ➝ $98.00
4/1/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$83.00 ➝ $87.00
3/24/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$82.00 ➝ $85.00
3/17/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$90.00 ➝ $90.00
3/3/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$86.00 ➝ $96.00
(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$170K38.87N/AN/A$0.20 per share0.46
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$18.51B3.42$6.64 per share13.34$51.35 per share1.72
FAP
abrdn Asia-Pacific Income Fund VCC
C$14.12M7.62C$0.44 per share6.60C$2.92 per share1.00
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$0.31N/AN/AN/A-12,594.21%-421.73%-147.54%N/A
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$4.53B$6.1415.2411.310.9711.35%12.68%1.10%7/15/2025 (Estimated)
FAP
abrdn Asia-Pacific Income Fund VCC
C$11.23MC$0.319.55N/A79.52%10.17%2.92%N/A
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/A25.86N/AN/AN/AN/AN/A

Latest FAP, BK, XLY, and AIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/11/2025Q1 2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$1.50$1.58+$0.08$1.58$4.76 billion$4.79 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
$1.882.12%+11.22%30.62%14 Years
FAP
abrdn Asia-Pacific Income Fund VCC
C$0.217.19%N/A68.71%N/A
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
$1.770.82%N/AN/AN/A

Latest FAP, BK, XLY, and AIM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/14/2025
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
quarterly$0.472.4%4/21/20254/21/20255/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.05
0.75
0.75
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
0.83
0.69
0.70
FAP
abrdn Asia-Pacific Income Fund VCC
44.38
2.85
0.30
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2072.29 million68.74 millionNot Optionable
The Bank of New York Mellon Co. stock logo
BK
Bank of New York Mellon
51,700715.43 million726.06 millionOptionable
FAP
abrdn Asia-Pacific Income Fund VCC
N/A36.86 millionN/ANot Optionable
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
147,00098.60 millionN/ANot Optionable

Recent News About These Companies

Oil Slumps to Below $60: ETFs to Gain
PCE Report Preview: TLT, Sector ETFs in Focus
Taking Apart the Tariff Impact With ETFs
Taking Apart the Tariff Impact With ETFs
Investors headline
3 Stocks Institutions Are Quietly Dumping (XLY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSE:AIM

$0.09 -0.03 (-22.34%)
As of 04/4/2025
This is a fair market value price provided by Polygon.io. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Bank of New York Mellon stock logo

Bank of New York Mellon NYSE:BK

$88.57 -0.50 (-0.56%)
As of 11:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. The company operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and other segments. The Securities Services segment offers custody, trust and depositary, accounting, exchange-traded funds, middle-office solutions, transfer agency, services for private equity and real estate funds, foreign exchange, securities lending, liquidity/lending services, and data analytics. This segment also provides trustee, paying agency, fiduciary, escrow and other financial, issuer, and support services for brokers and investors. The Market and Wealth Services segment offers clearing and custody, investment, wealth and retirement solutions, technology and enterprise data management, trading, and prime brokerage services. This segment also provides integrated cash management solutions, including payments, foreign exchange, liquidity management, receivables processing and payables management, and trade finance and processing services. The Investment and Wealth Management segment offers investment management strategies and distribution of investment products, investment management, custody, wealth and estate planning, private banking, investment, and information management services. The Other segment engages in the provision of leasing, corporate treasury, derivative and other trading, corporate and bank-owned life insurance, renewable energy investment, and business exit services. It serves central banks and sovereigns, financial institutions, asset managers, insurance companies, corporations, local authorities and high net-worth individuals, and family offices. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

abrdn Asia-Pacific Income Fund VCC TSE:FAP

C$2.92 -0.03 (-1.02%)
As of 11:09 AM Eastern

The investment objective of the Company is to obtain current income and achieve incidental capital appreciation from investment in long-term securities. The Company seeks to obtain these objectives primarily from investment in long-term debt securities. The Company may invest up to 100 percent of its total assets in Asia-Pacific debt securities.

Consumer Discretionary Select Sector SPDR Fund stock logo

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

$214.90 -0.07 (-0.03%)
As of 11:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc.